Loading…
Eureka International Summer Course in Translational Medicine...
arrow_back View All Dates
Tuesday, July 7
 

08:15 CEST

Coffee
Tuesday July 7, 2026 08:15 - 08:30 CEST
Tuesday July 7, 2026 08:15 - 08:30 CEST
TBA

08:30 CEST

Morning Primer
Tuesday July 7, 2026 08:30 - 08:50 CEST
A reflection on the previous day's learnings and a grounding in how the current day's sessions are critical to Translational Medicine.
Speakers
avatar for Richard Foty

Richard Foty

Director of Epidemiology & Data Analytics, Respond Health, HealthEdge Innovation
Richard Foty is the Director of Epidemiology & Data Analytics at Respond Health, where he is helping to develop and leverage sophisticated techniques in AI to draw critical intelligence from the largest health dataset in the USA. His work focuses on translating complex data into actionable... Read More →
avatar for Marc van Mil

Marc van Mil

Associate Professor Biomedical Education, UMC Utrecht
Marc van Mil is associate professor biomedical education at University Medical Center Utrecht, the Netherlands. He cares about and contributes to the professional development of future clinicians, clinician scientists and biomedical scientists; both by being an excellent teacher and... Read More →
Tuesday July 7, 2026 08:30 - 08:50 CEST
TBA

08:50 CEST

Welcome to Danone
Tuesday July 7, 2026 08:50 - 09:05 CEST
If you're interested in speaking further with Johan Garssen, you can reach him at: J[email protected]
Tuesday July 7, 2026 08:50 - 09:05 CEST
TBA

09:05 CEST

Introduction to the Case Study
Tuesday July 7, 2026 09:05 - 09:15 CEST
Speakers
avatar for Marc van Mil

Marc van Mil

Associate Professor Biomedical Education, UMC Utrecht
Marc van Mil is associate professor biomedical education at University Medical Center Utrecht, the Netherlands. He cares about and contributes to the professional development of future clinicians, clinician scientists and biomedical scientists; both by being an excellent teacher and... Read More →
Tuesday July 7, 2026 09:05 - 09:15 CEST
TBA

09:15 CEST

Innovation in Translational Medicine: Why Intellectual Property Matters
Tuesday July 7, 2026 09:15 - 10:15 CEST
Intellectual property (IP) is a critical component of innovation in translational medicine, providing the legal protection necessary to safeguard novel ideas and inventions. Often overlooked in scientific training, IP is essential not only for commercialization but also for ensuring that research can be successfully translated to benefit patients. This session will cover the basics of intellectual property, its significance in the translational medicine process, and why and when researchers should start considering IP. We will discuss how early IP considerations can significantly impact the success of translating research into practical applications. The session will also relate these principles and their practical application to our case study.
Learning Objectives:
  1. Understand the basics of intellectual property and its role in protecting innovation.
  2. Recognize the importance of intellectual property in translational medicine, beyond just commercialization.
  3. Apply intellectual property principles to the ongoing case study, illustrating their practical significance and timing consideration.
Speakers
avatar for Claudia Ogilvie

Claudia Ogilvie

Patent attorney, De Vries & Metman
Claudia Ogilvie is a senior patent attorney specialized in patent drafting, patent prosecution, and patent counselling in the biochemical and pharmaceutical field. Her technical expertise includes antibody and vaccine technology, (bio)pharmaceuticals, and diagnostic and prognostic... Read More →
Tuesday July 7, 2026 09:15 - 10:15 CEST
TBA

10:15 CEST

Break + Coffee
Tuesday July 7, 2026 10:15 - 10:30 CEST
Tuesday July 7, 2026 10:15 - 10:30 CEST
TBA

10:30 CEST

De-Risking Health Tech Innovation: Applying the Scientific Method to Business Decisions
Tuesday July 7, 2026 10:30 - 11:30 CEST
Health tech entrepreneurs and their investors face high-stakes decisions under deep uncertainty. In this session, Luigi Negri draws on 20+ years in pharma and health technology innovation to present a decision-making methodology grounded in the scientific method. Drawing from his newly published Springer book, De-Risking Investments in Medical Technology Innovation, he shares evidence from a comparative study showing that startups applying scientific rigor to business decisions actually move faster than those relying on intuition alone. The session explores how translational scientists can apply these principles as they consider entrepreneurial paths.
Learning Objectives:
  1. Understand how the scientific method can be applied to business and investment decisions in health tech.
  2. Identify common failure modes in health tech startups and how evidence-based approaches mitigate risk.
  3. Reflect on the intersection of scientific training and entrepreneurial thinking in translational medicine careers.
Speakers
LN

Luigi Negri

Managing Partner; Venture Partner, ThinKeen Global Consulting; Obloo Ventures
Tuesday July 7, 2026 10:30 - 11:30 CEST
TBA

11:30 CEST

Lunch
Tuesday July 7, 2026 11:30 - 12:30 CEST
Tuesday July 7, 2026 11:30 - 12:30 CEST
TBA

12:30 CEST

Personal Journey
Tuesday July 7, 2026 12:30 - 12:45 CEST
In these 15-minute sessions, scientists and clinicians who previously attended a Eureka course share their personal experiences and the impact the course had on their careers. Each speaker will provide insights into how the knowledge and skills they gained have been applied in their professional journeys.
Tuesday July 7, 2026 12:30 - 12:45 CEST
TBA

12:45 CEST

Danone Tour and Group Picture
Tuesday July 7, 2026 12:45 - 13:45 CEST
Tuesday July 7, 2026 12:45 - 13:45 CEST
TBA

13:45 CEST

Leveraging AI and Real-World Data in Translational Medicine: Shaping the Future
Tuesday July 7, 2026 13:45 - 14:45 CEST
In this session, we'll explore how AI and real-world data can disrupt current research practices by providing insights that help identify unmet needs and focus research efforts more effectively. By thinking big picture, we will discuss how to move forward and apply these advanced tools to make meaningful impacts on patient outcomes. This session aims to inspire and equip participants with a forward-looking perspective on their role in advancing translational medicine.
Learning Objectives:
  1. Synthesize key learnings from the week's sessions and understand their practical applications.
  2. Explore how AI can leverage real-world data to identify unmet needs and direct research efforts.
  3. Discuss strategies for integrating AI insights into translational research to improve patient outcomes.
  4. Reflect on future directions in translational medicine and how to contribute to these advancements.
 
Click here to demo Respond.SME
Password: utrecht2025
 
Click here to leave us feedback on Respond.SME
Speakers
avatar for Richard Foty

Richard Foty

Director of Epidemiology & Data Analytics, Respond Health, HealthEdge Innovation
Richard Foty is the Director of Epidemiology & Data Analytics at Respond Health, where he is helping to develop and leverage sophisticated techniques in AI to draw critical intelligence from the largest health dataset in the USA. His work focuses on translating complex data into actionable... Read More →
avatar for Vicki Seyfert-Margolis

Vicki Seyfert-Margolis

Respond health
Dr. Seyfert-Margolis founded RespondHealth (previously known as My Own Med, Inc.) to disrupt incumbent methods of clinical trialing, new product trialing and patient registry development – all in service of her aim to deliver better health outcomes to those afflicted with disease... Read More →
Tuesday July 7, 2026 13:45 - 14:45 CEST
TBA

14:45 CEST

Break
Tuesday July 7, 2026 14:45 - 15:00 CEST
Tuesday July 7, 2026 14:45 - 15:00 CEST
TBA

15:00 CEST

Case Study Group 1
Tuesday July 7, 2026 15:00 - 16:30 CEST
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

15:00 CEST

Case Study Group 2
Tuesday July 7, 2026 15:00 - 16:30 CEST
Speakers
avatar for Roos de Jonge

Roos de Jonge

Assistant professor community engaged learning, UMC Utrecht
Roos de Jonge studied Medical Biology at the University of Amsterdam and obtained her PhD in the AMC at the Department of Neurosience with the topic: "Genetic profiling of the peripheral nervous system". Due to an extensive role as a caregiver for her daughter with a congenital heart... Read More →
avatar for Norm Rosenblum

Norm Rosenblum

Pediatric Nephrologist, Senior Scientist, SickKids, U Toronto
Dr. Norman Rosenblum is Professor of Paediatrics, Physiology, and Laboratory Medicine and Pathobiology at the University of Toronto, a Paediatric Nephrologist and Senior Scientist at the Hospital for Sick Children, and Scientific Director of the Canadian Institutes of Health Research... Read More →
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

15:00 CEST

Case Study Group 3
Tuesday July 7, 2026 15:00 - 16:30 CEST
Speakers
avatar for Berent Prakken

Berent Prakken

Emeritus professor, UMC Utrecht
Berent Prakken (MD, PhD) is vice-dean and director of the biomedical education centre at the Utrecht Medical Center Utrecht (UMCU), the Netherlands. He is also professor of pediatric immunology at the UMCU and honorary professor at the University of Ghent, Belgium. Berent Prakken... Read More →
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

15:00 CEST

Case Study Group 4
Tuesday July 7, 2026 15:00 - 16:30 CEST
Speakers
ST

Sanne ter Meulen

Assistant professor, UMC Utrecht
Biography Sanne ter Meulen – de Jong, PhDSanne ter Meulen is assistant professor in biomedical education at University Medical Center Utrecht, The Netherlands. She obtained her PhD at the department Medical Physiology of the UMC Utrecht in 2015, concerning the detection of cardiac... Read More →
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

15:00 CEST

Case Study Group 5
Tuesday July 7, 2026 15:00 - 16:30 CEST
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

15:00 CEST

Case Study Group 6
Tuesday July 7, 2026 15:00 - 16:30 CEST
Speakers
avatar for Ernest Diez Benavente

Ernest Diez Benavente

Assistant Professor, University Medical Center Utrecht
As an Assistant Professor in experimental cardiology at the UMC Utrecht (Netherlands) my group focusses on the analysis of complex biological data to understand sex differences in atherosclerosis. In addition, we have a strong motivation to valorise our findings into clinically relevant... Read More →
avatar for Vicki Seyfert-Margolis

Vicki Seyfert-Margolis

Respond health
Dr. Seyfert-Margolis founded RespondHealth (previously known as My Own Med, Inc.) to disrupt incumbent methods of clinical trialing, new product trialing and patient registry development – all in service of her aim to deliver better health outcomes to those afflicted with disease... Read More →
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

15:00 CEST

Translating Innovation: A Collaborative Case Study 1
Tuesday July 7, 2026 15:00 - 16:30 CEST
Session Description:
This session invites participants to immerse themselves in a multi-day, unfolding case study rooted in the real-world complexities of translating an early scientific discovery into a potential therapeutic intervention. The case simulates the iterative process of decision-making under uncertainty, encouraging participants to explore what it takes to move a promising innovation forward within a multidisciplinary and stakeholder-rich environment. This experience is less about finding the “right” answer and more about learning to ask the right questions.
 
Learning Objectives:
  1. Explore the breadth of translational challenges involved in moving scientific discovery toward clinical and societal impact, especially in the context of paediatric oncology.
  2. Develop skills in cross-disciplinary collaboration, critical thinking, and stakeholder engagement required to navigate real-world innovation pathways.
  3. Reflect on the role of ambiguity, iteration, and diverse perspectives in shaping the translational process—from early preclinical work through to clinical trial design and beyond.
 
Tuesday July 7, 2026 15:00 - 16:30 CEST
TBA

16:30 CEST

Break + Coffee
Tuesday July 7, 2026 16:30 - 16:45 CEST
Tuesday July 7, 2026 16:30 - 16:45 CEST
TBA

16:45 CEST

Reflections on Translation: Lessons from the Case Study
Tuesday July 7, 2026 16:45 - 17:45 CEST
Session Description:
In this facilitated discussion, we revisit the case study experience through the eyes of participants and a panel of experts who have walked similar paths in real-world translational medicine. Together, we’ll reflect on the decisions made, the uncertainties faced, and the multidisciplinary perspectives required to move a promising innovation forward. This session is not about evaluating performance but about surfacing insights, challenging assumptions, and exploring the broader themes that emerged. Participants will have the chance to pose questions, share takeaways, and consider how this experience might shape their approach to future translational challenges.
 
Learning Objectives:
  1. Reflect critically on the translational case study experience, identifying key decision points, trade-offs, and moments of uncertainty.
  2. Engage in dialogue with experienced practitioners, drawing connections between the case and real-world examples of translational medicine.
  3. Synthesize themes across the case study, including ethical considerations, stakeholder alignment, evidence generation, and clinical applicability.
Speakers
avatar for Ernest Diez Benavente

Ernest Diez Benavente

Assistant Professor, University Medical Center Utrecht
As an Assistant Professor in experimental cardiology at the UMC Utrecht (Netherlands) my group focusses on the analysis of complex biological data to understand sex differences in atherosclerosis. In addition, we have a strong motivation to valorise our findings into clinically relevant... Read More →
avatar for Marc van Mil

Marc van Mil

Associate Professor Biomedical Education, UMC Utrecht
Marc van Mil is associate professor biomedical education at University Medical Center Utrecht, the Netherlands. He cares about and contributes to the professional development of future clinicians, clinician scientists and biomedical scientists; both by being an excellent teacher and... Read More →
Tuesday July 7, 2026 16:45 - 17:45 CEST
TBA

17:45 CEST

Evaluation Survey Day 3
Tuesday July 7, 2026 17:45 - 18:00 CEST
Tuesday July 7, 2026 17:45 - 18:00 CEST
TBA
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date -